Elevance Health, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Elevance Health, Inc. regarding compliance with federal securities laws [1] Group 1: Investigation Details - The investigation is prompted by a disclosure from Elevance on February 27, 2026, indicating that the Centers for Medicare & Medicaid Services intends to impose intermediate sanctions on the company [3] - The sanctions will suspend enrollment into certain Medicare Advantage-Prescription Drug plans and halt communications to Medicare beneficiaries, effective March 31, 2026, unless issues are resolved [3] Group 2: Investor Information - Investors who purchased Elevance securities and experienced losses are encouraged to join the investigation [2][4] - Johnson Fistel offers assistance without any cost or obligation to the investors [2]